Taking Mounjaro every other week to maintain weight: what the evidence actually says

The misconception: spacing out injections will lock in your weight loss

A question our prescribers hear most weeks goes something like this: "I've hit my target weight, can I just take my pen every fortnight to stay here?" It's a reasonable instinct. You've done the hard work, the number on the scale has settled, and reducing how often you inject feels like a logical next step. The problem is that tirzepatide doesn't work that way.

Mounjaro suppresses appetite and slows gastric emptying by activating GIP and GLP-1 receptors. Both effects are tied to maintaining a therapeutic level of the medicine in your system week to week. Stretch the gap to fourteen days and concentrations drop, appetite signals begin returning, and the biological drivers of weight regain (which don't simply disappear because you've lost weight) start reasserting themselves. If you're weighing up how long you can realistically take Mounjaro every other week, the short answer is that there's no published evidence an every-other-week schedule preserves the results a weekly schedule built. The NHS's patient information for tirzepatide is clear that the medicine is taken once weekly; no approved variation exists for fortnightly use.

That's not to say your dose has to stay at its highest level forever. But the right question isn't "how often", it's "at what dose, and for how long," which is a clinical conversation rather than a personal experiment.

What happens to weight when Mounjaro is stopped or reduced, and why it matters here

The evidence on what happens after stopping tirzepatide is instructive for the fortnightly question too. Data from the SURMOUNT programme, involving thousands of adults, showed that when treatment ended, participants regained a meaningful portion of the weight they had lost, even after 72 weeks of successful treatment. The weight-regulatory biology that the medicine was modulating doesn't permanently reset.

Reducing dosing frequency is a softer version of the same thing: the drug's effect diminishes, and the underlying physiology reasserts. If you're curious about how long results typically last on the current schedule, the timeline of how Mounjaro works is worth reading alongside this. For a fuller look at what evidence-based weight maintenance looks like after treatment, the NICE appraisal of tirzepatide (TA1026) outlines the expectation that patients losing less than 5% of body weight at the highest tolerated dose should have their treatment reviewed, a framework that signals how seriously the guidance takes dose integrity.

The practical upshot: reducing to fortnightly doesn't sit in a grey zone of unofficial but harmless tweaks. It risks undoing results that took months to build, and it does so without any clinical data to suggest it would work.

What prescribers actually do when the goal shifts to maintenance

There are legitimate clinical conversations to have once you've reached a stable weight. A prescriber might consider whether your current dose remains appropriate, whether a lower weekly dose could maintain your results with a more comfortable side-effect profile, and what lifestyle factors are supporting (or undermining) the position you've reached. These are not conversations to have in isolation.

Some patients do eventually reduce their dose under supervision, and there is a difference between a supervised, evidence-informed dose adjustment and unilaterally stretching injections to save money. The question of using Mounjaro specifically for maintenance covers this terrain in more detail, including what the clinical guidance says about long-term use. For people already thinking beyond Mounjaro, maintaining weight loss after stopping addresses the behavioural and physiological factors that matter once treatment ends.

Cost is a real consideration, and if the current price of weekly treatment feels unsustainable, that's worth raising directly with your prescriber rather than self-adjusting the schedule. A transparent picture of what treatment involves (clinically and financially) is part of what the weight loss treatment overview at nume is designed to provide.

The honest bottom line on every-other-week dosing

There is no approved, evidence-supported fortnightly maintenance schedule for Mounjaro. The licensed use is once weekly. Stretching doses without clinical guidance carries a real risk of weight regain, and it falls outside the framework your prescriber can safely monitor. If your goal is long-term weight maintenance, the most productive step is a review with your prescriber to look at your current dose, your trajectory, and what comes next, whether that's continuing at the same dose, discussing a supervised reduction, or planning an exit strategy with support.

The evidence on maintaining results after tirzepatide is a useful read before that conversation. And if you're at an earlier stage (still deciding whether Mounjaro is right for you at all) the Mounjaro overview covers the full picture from licensing through to what treatment involves day to day. For anything specific to your own situation, speaking to a prescriber is the right move. Speak to our prescribers through a free consultation and get a clinical view on what your next step should actually look like.